Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33958344.
- Also identified by DOI 10.3949/ccjm.88a.ccc078.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vaccine-induced thrombotic thrombocytopenia (VITT) has been reported after vaccination with the AztraZeneca ChAdOx1 nCoV-19 and the Johnson and Johnson Ad26. COV2.S vaccines. This manuscript provides a brief overview of reported cases, clinical and laboratory features, and current understanding of the pathogenesis of VITT. The author also poses unananswered questions and identifies directions for future study.